Neuphoria Therapeutics (NEUP) Q2 2026 Earnings

May 15Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-4.41
-3.13
-1.84
-0.56

Details

Expected EPS
-0.56
Actual EPS
-0.56
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Neuphoria Therapeutics⁩ (⁦NEUP⁩) has reported earnings of ⁦-0.56⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts